The lungs are a frequent target of metastatic breast cancer cells, but the underlying molecular mechanisms are unclear. All existing data were obtained either using statistical association between gen
We predicted patient states using gene-expression and clinical predictors (Analysis 5). Using each respective training set, we performed feature selection for each of 14 feature-selection algorithms a
Sorafenib is tyrosine kinase inhibitory drug with multiple molecular specificities that is approved for clinical use in second line treatments of metastatic and advanced renal cell carcinomas (RCCs).
